RecruitingPhase 1DMT
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Sponsored by Yale University
NCT ID
NCT06070649
Target Enrollment
63 participants
Start Date
2025-08-04
Est. Completion
2026-08-01
About This Study
This proposed study is a double-blind, randomized, placebo-controlled, parallel-group, laboratory study to determine the effects of DMT, plus psychotherapy, on Alcohol Use Disorder.
Conditions Studied
Interventions
- •0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
- •0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion
- •25 mg Diphenhydramine (5 min) + Normal Saline
Eligibility
Age:21 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5) diagnosis of Alcohol Use Disorder * Medically healthy * Ability to provide consent Exclusion Criteria: * Unstable medical conditions
Study Locations (1)
Connecticut Mental Health Center
New Haven, Connecticut, United States